cryptolepine monohydrochloride has been researched along with Neuroblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, HS; de Oliveira, AC; Fiebich, BL; Olajide, OA; Wright, CW | 1 |
1 other study(ies) available for cryptolepine monohydrochloride and Neuroblastoma
| Article | Year |
|---|---|
Anti-neuroinflammatory properties of synthetic cryptolepine in human neuroblastoma cells: possible involvement of NF-κB and p38 MAPK inhibition.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents; Cell Line, Tumor; Cryptolepis; Cyclooxygenase 2; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Immunoblotting; Indole Alkaloids; Interleukin-1beta; Intramolecular Oxidoreductases; Molecular Structure; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Prostaglandin-E Synthases; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factor RelA | 2013 |